… real‐world associations of RAAS i dose, hyperkalemia, and adverse clinical outcomes in a
large cohort of UK cardiorenal patients. … of this study emphasize the potential negative impact …

… the effect of MRA use on the risk of progression to KFRT in a real-world CKD population. …
between MRA use and hard renal outcomes in a large, real-world CKD population. Even after …

… The results of analyses according to the subtype of psoriasis are listed in Table 3. In the …
Cyclosporin is reportedly nephrotoxic 39 , but in this study, cyclosporin did not impact the risk of …

… assess renal outcomes in a large cohort of 4401 patients with … effect of canagliflozin on the
kidney in diabetic CKD patients and… in patients with the worst kidney function and more severe …

… cardiovascular disease (ASCVD) in patients with T2DM in … of lipids, heart failure and chronic
kidney disease (CKD) (referred … However, the effects of GLP1RA on kidney function decline …

… renal denervation (RDN). The long-term safety and efficacy after RDN in real-world patients
… to assess the long-term safety and efficacy of RDN, including its effects on renal function. …

… kidney disease among those with CKD (12), and its effect on cardiovascular and kidney
outcomes … and Mortality in Participants With Heart Failure and Left Ventricular Ejection Fraction …

… Evaluating real-world evidence focusing on short- and long-… effect on kidney disease trajectory
(ie, slow or reverse kidney … and increased satisfaction among patients with kidney failure …

… Furthermore, the effect of the biological interaction 16-19 between DR and DKD on mortality…
The results of these two studies are essentially consistent with the results of the present study…

… of CKD using clinical events, kidney function and patient-… events could provide a framework
for comparison with real-world … of kidney disease (KDQOL Burden), a score for the effects of …